Stock listing

NASDAQ:AGMB AgomAb Therapeutics NV Stock

Follow AgomAb Therapeutics NV into a list and get an email when it puts out news.

Share price · NASDAQ:AGMB

$5.45 USD -0.37 (-6.4%)

Close on Nov 20, 2026

Since Feb 5, 2026 -65.9% · daily closes, Feb 5, 2026 – Nov 20, 2026, adjusted for splits
Day range
$5.39 – $5.78 USDNov 20, 2026
Volume
188,938 sharesNov 20, 2026
Market cap
$268.4M USDAt the close on Nov 20, 2026 · price × 49.25M shares outstanding
Traded on an average day
$1.91M USDMedian day 129,600 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
AgomAb Therapeutics NV logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:AGMB · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.45-0.37-6.4%$5.51$5.78$5.39188,938
$5.82-0.10-1.7%$6.00$6.25$5.70131,857
$5.92-0.05-0.8%$6.00$6.435$5.50296,439
$5.97-0.39-6.1%$6.36$6.505$5.90165,616
$6.360.000.0%$6.32$6.605$5.731192,639
$6.36-0.63-9.0%$6.90$6.98$6.191,517,921
$6.990.000.0%$7.07$7.23$6.85433,254
$6.99-0.56-7.4%$7.54$7.75$6.80447,059
$7.55-0.085-1.1%$7.72$8.245$7.32661,382
$7.635+0.665+9.5%$7.09$8.15$7.005158,411
$6.97+0.12+1.8%$6.85$7.46$6.47780,328
$6.850.000.0%$7.00$7.085$6.7679,984
$6.85+0.13+1.9%$6.67$7.155$6.6740,243
$6.72-0.77-10.3%$7.57$8.111$6.548105,630
$7.49-0.46-5.8%$7.00$7.955$6.61197,833
$7.95-0.01-0.1%$7.98$8.292$7.47575,393
$7.96-0.44-5.2%$8.37$8.37$7.71105,583
$8.40-0.17-2.0%$8.60$8.60$7.8889,797
$8.57-0.48-5.3%$9.10$9.33$8.4473,647
$9.05-0.21-2.3%$9.15$9.184$8.67549,125
$9.26+0.15+1.6%$9.15$9.44$8.9084,322
$9.11+0.38+4.4%$8.74$9.22$8.7442,422
$8.73+0.50+6.1%$8.24$8.97$8.2335,303
$8.23-0.05-0.6%$8.28$8.61$8.1631,092
$8.28-0.05-0.6%$8.21$8.53$7.9278,133
$8.33-0.36-4.1%$8.56$8.86$8.1597,715
$8.69-0.12-1.4%$8.80$9.08$8.5157,697
$8.81-0.28-3.1%$9.05$9.35$8.7359,400
$9.09+0.01+0.1%$9.18$9.65$9.0562,300
$9.08-0.14-1.5%$9.36$9.49$8.92102,100
$9.22+0.42+4.8%$8.88$9.45$8.56225,200
$8.80-0.04-0.5%$8.95$9.35$8.68104,900
$8.84+0.15+1.7%$8.77$8.97$8.40103,900
$8.69+0.13+1.5%$8.51$8.71$7.97129,600
$8.56-0.09-1.0%$8.65$9.34$8.00388,700
$8.65-2.45-22.1%$11.21$11.32$8.56639,200
$11.10+0.57+5.4%$10.62$11.36$10.58133,700
$10.53+0.32+3.1%$10.23$10.69$10.14113,500
$10.21-0.30-2.9%$10.51$10.54$9.87147,200
$10.51-0.07-0.7%$10.65$11.23$10.41164,000
$10.58-0.19-1.8%$10.75$10.99$10.5064,200
$10.77-0.72-6.3%$11.54$11.80$10.6498,700
$11.49-0.21-1.8%$11.70$11.85$11.3149,400
$11.70-0.47-3.9%$12.26$12.26$11.2885,400
$12.17+0.09+0.7%$12.26$12.99$11.60250,700
$12.08+0.67+5.9%$11.66$12.46$11.62339,300
$11.41-0.75-6.2%$12.26$12.85$11.21120,300
$12.16-0.12-1.0%$12.31$12.92$11.61146,300
$12.28-0.78-6.0%$13.20$13.29$12.2086,200
$13.06-0.88-6.3%$14.00$14.10$12.96196,700
$13.94-1.02-6.8%$14.91$16.40$13.75106,700
$14.96+0.05+0.3%$14.94$15.70$14.6572,600
$14.91-0.87-5.5%$15.78$16.50$14.51260,600
$15.78+0.95+6.4%$14.83$15.86$14.53245,300
$14.83+1.17+8.6%$13.67$14.94$13.59407,900
$13.66+0.12+0.9%$13.29$13.96$13.19158,900
$13.54+0.37+2.8%$12.90$13.99$12.62241,300
$13.170.000.0%$13.15$14.13$12.75105,400
$13.17-0.67-4.8%$13.84$14.20$12.84252,900
$13.84-0.44-3.1%$14.26$14.37$13.66154,200
$14.28+0.26+1.9%$14.19$14.60$13.58243,700
$14.02+1.20+9.4%$13.40$14.26$13.16219,354
$12.82-0.43-3.2%$13.21$13.23$12.7631,651
$13.25-0.18-1.3%$13.50$13.64$13.0768,400
$13.43-0.32-2.3%$13.74$13.85$13.0192,200
Ticker
NASDAQ:AGMB
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All AgomAb Therapeutics NV news

Financings

  • Public offering of american Depositary Shares

    Feb 9, 2026

    Closed: US$200M raised · US$16 a share · J.P. Morgan +3

    Dealers: J.P. Morgan (co-lead), Morgan Stanley (co-lead), Leerink Partners (co-lead), Van Lanschot Kempen (co-lead)

    Announced Feb 6, 2026 · Closed Feb 9, 2026

Read by 6ix AI from the company's releases

Decks

AgomAb Therapeutics NV on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 16 in all · newest Nov 4, 2026 · oldest 2026
Decks
2 decks · latest Oct 1, 2026

Log in to ask 6ix AI your own questions about AgomAb Therapeutics NV.